Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

Market Cap	14.65B
Revenue (ttm)	5.10B
Net Income (ttm)	945.83M
Shares Out	663.61M
EPS (ttm)	1.43
PE Ratio	15.43
Forward PE	13.72
Dividend	0.64 (2.91%)
Ex-Dividend Date	Jun 27, 2025

Volume	9,785,861
Average Volume	10,650,670
Open	22.04
Previous Close	22.07
Day's Range	21.95 - 22.28
52-Week Range	21.13 - 32.00
Beta	0.39
RSI	54.02
Earnings Date	Aug 26, 2025

About SHA:600529

Shandong Pharmaceutical Glass Co.Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection vial comprising type I/II/III. It also provides tubular glass products, such as glass tubes for pharma use, other tubular bottle with screw neck finish, PFS and glass cartrid...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1970
• Employees: 7,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600529

Financial Performance

In 2024, SHA:600529's revenue was 5.13 billion, an increase of 2.87% compared to the previous year's 4.98 billion. Earnings were 942.99 million, an increase of 21.55%.